Avapritinib (Ayvakit)

avapritinib · Blueprint Medicines / Genentech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Avapritinib (Ayvakit), covering 2025-01-09 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Avapritinib Maintenance for AML With KIT Mutations [Phase 2]